Clinical Trial Update: Phase II Study With Hiltonol and Dendritic Cells in Solid Tumors [Phase 2]

View source ↗

Summary

Phase II trial update notes completion of a study evaluating Hiltonol (poly-ICLC) in combination with autologous dendritic cells in solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Dendritic cells
• Hiltonol (Poly-ICLC)

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Neoplasms | Phase 2 | Status: COMPLETED